• Eli Lilly's oral RET inhibitor selpercatinib received priority review by the US FDA!
  • 2020-03-02
  • January 29, 2020,Eli Lilly recently announced that the US Food and Drug Administration (FDA) has accepted new drug applications (NDA) for selpercatinib (LOXO-292) and granted priority review. That the drug is an oral RET kinase inhibitor
>
  • Roche Alecensa is approved for new indications for the treatment of ALK-positive anaplastic large
  • 2020-03-02
  • February 23, 2020,Chugai, a Japanese pharmaceutical company controlled by Roche, recently announced that the Ministry of Health, Labor and Welfare (MHLW) has approved the targeted anticancer drug Alecensa(alectinib)150mg capsules a new indication for
>
  • Cloud computing deeply empowers the gene industry to help rapid development of gene sequencing
  • 2020-02-27
  • In 2018, Huawei Cloud launched the worlds first gene container service GCS (GeneContainer Service), which makes the calculation of gene sequencing data more economical, faster, and easier. After using GCS, it achieved the goal of reducing the efficiency
>
  • QIAGEN announced to stop the development of next-generation sequencers
  • 2020-02-27
  • In 2015, QIAGEN announced the official launch of the commercialization of the fully automated next-generation sequencing platform GeneReader NGS System, and launched the first complete next-generation sequencing (NGS)
>